Location History:
- Shimotsuga, JP (1994)
- Minamikawachimachi, JP (2007)
- Tochigi, JP (2005 - 2009)
Company Filing History:
Years Active: 1994-2009
Title: Hisataka Yasuda: Innovator in Bone Disease Treatment
Introduction
Hisataka Yasuda is a prominent inventor based in Tochigi, Japan, known for his significant contributions to the field of bone disease treatment. With a total of 11 patents to his name, Yasuda has made remarkable advancements in the understanding and treatment of conditions affecting bone health.
Latest Patents
Yasuda's latest patents focus on methods of reducing bone absorption through the administration of antibodies that bind to osteoclastogenesis inhibitory factor (OCIF). His innovations include novel proteins and polypeptides that interact with OCIF-binding molecules (OBMs) and nucleic acids encoding these proteins. These advancements provide processes for producing these proteins and nucleic acids via genetic engineering. Additionally, Yasuda has developed medicinal compounds that incorporate these proteins and nucleic acids, which can be utilized in treating bone diseases. His research also includes nucleic acid molecules that encode proteins inhibiting osteoclast differentiation and maturation, produced by human embryonic lung fibroblasts.
Career Highlights
Throughout his career, Yasuda has worked with notable companies such as Sankyo Company, Limited and Daiichi Sankyo Company, Limited. His work has significantly impacted the pharmaceutical industry, particularly in the development of treatments for bone-related ailments.
Collaborations
Yasuda has collaborated with esteemed colleagues, including Tomonori Morinaga and Kanji Higashio, to further his research and innovations in the field.
Conclusion
Hisataka Yasuda's contributions to the treatment of bone diseases through innovative research and development of new therapeutic compounds highlight his role as a leading inventor in this critical area of medicine. His work continues to pave the way for advancements in bone health treatments.